Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Gomez-Pinillos

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Hematology/Oncology Clinics of North America|April 24, 2012
mTOR signaling pathway and mTOR inhibitors in cancer therapyAlejandro Gomez-Pinillos, Anna C Ferrari
The Prostate|October 1, 2009
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levelsXiaomei Liu, Alejandro Gomez-Pinillos, Xiaojun Liu, et al.
The Canadian Journal of Urology|October 25, 2011
Immunotherapy in the treatment of advanced prostate cancerBob Djavan, Kathleen Nelson, Amir Kazzazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
The American Journal of Pathology|July 24, 2012
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivationXiaoMei Liu, Alejandro Gomez-Pinillos, Charisse Loder, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|April 24, 2012
mTOR signaling pathway and mTOR inhibitors in cancer therapyAlejandro Gomez-Pinillos, Anna C Ferrari
The Prostate|October 1, 2009
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levelsXiaomei Liu, Alejandro Gomez-Pinillos, Xiaojun Liu, et al.
The Canadian Journal of Urology|October 25, 2011
Immunotherapy in the treatment of advanced prostate cancerBob Djavan, Kathleen Nelson, Amir Kazzazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
The American Journal of Pathology|July 24, 2012
KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivationXiaoMei Liu, Alejandro Gomez-Pinillos, Charisse Loder, et al.
Pageof 1